Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brincidofovir for Serious dsDNA Virus Infections
NCT01143181Phase 3Completed
- Sponsor
- Chimerix Inc.
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of brincidofovir in cytomegalovirus infection (CMV), adenovirus infection, herpes simplex virus infection, vaccinia virus infection, smallpox, sponsored by Chimerix Inc.. Started Dec 2010; status: completed.
02
Drugs
brincidofovir
03
Conditions
cytomegalovirus infection (CMV)adenovirus infectionherpes simplex virus infectionvaccinia virus infectionsmallpox
Beyond the preview
Go deeper on NCT01143181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143181.